Hadjadj S, Aubert R, Fumeron F, Pean F, Tichet J, Roussel R, Marre M
Department of Endocrinology and Diabetology, University Hospital, BP 577, 86021, Poitiers Cedex, France.
Diabetologia. 2005 Jun;48(6):1088-92. doi: 10.1007/s00125-005-1747-x. Epub 2005 May 5.
AIMS/HYPOTHESIS: Insulin resistance is related to an increased risk of diabetic retinopathy and nephropathy in type 1 diabetes. Patients with insulin resistance and/or macrovascular disease have abnormally low levels of adiponectin. The aim of this study was to investigate the relationships between adiponectin and renal and retinal diabetic complications in type 1 diabetic patients.
In this 6-year prospective follow-up observational study, we evaluated the severity of retinopathy at baseline and determined the incident risk of microalbuminuria in 126 normoalbuminuric patients with type 1 diabetes. Each patient was age- and sex-matched to two non-diabetic control subjects.
Plasma adiponectin concentrations were significantly higher in diabetic subjects than in control subjects (p < 0.0001). The adiponectin concentration was significantly higher in patients with severe diabetic retinopathy than in those without (39.1+/-14.0 vs 29.0+/-13.0 microg/ml, p = 0.0005). The 18 patients who developed persistent microalbuminuria had higher adiponectin concentrations than the other patients (35.8+/-14.5 vs 30.6+/-13.7 microg/ml). Increased adiponectin concentrations were independently associated with the occurrence of microalbuminuria (p = 0.0158) after adjustment for baseline urinary albumin concentration (p = 0.004), sex (p = 0.0054), blood pressure (NS) and metabolic control (NS).
CONCLUSIONS/INTERPRETATION: The elevated adiponectin concentrations observed in subjects with microvascular disease may indicate an altered regulation of this adipocytokine in patients with complications associated with type 1 diabetes.
目的/假设:胰岛素抵抗与1型糖尿病患者发生糖尿病视网膜病变和肾病的风险增加有关。胰岛素抵抗和/或大血管疾病患者的脂联素水平异常低。本研究的目的是调查1型糖尿病患者脂联素与糖尿病肾脏和视网膜并发症之间的关系。
在这项为期6年的前瞻性随访观察研究中,我们评估了126例正常白蛋白尿的1型糖尿病患者基线时视网膜病变的严重程度,并确定了微量白蛋白尿的发病风险。每位患者在年龄和性别上与两名非糖尿病对照受试者相匹配。
糖尿病受试者的血浆脂联素浓度显著高于对照受试者(p < 0.0001)。重度糖尿病视网膜病变患者的脂联素浓度显著高于无病变患者(39.1±14.0对29.0±13.0μg/ml,p = 0.0005)。发生持续性微量白蛋白尿的18例患者的脂联素浓度高于其他患者(35.8±14.5对30.6±13.7μg/ml)。在调整基线尿白蛋白浓度(p = 0.004)、性别(p = 0.0054)、血压(无显著性差异)和代谢控制(无显著性差异)后,脂联素浓度升高与微量白蛋白尿的发生独立相关(p = 0.0158)。
结论/解读:在微血管疾病患者中观察到的脂联素浓度升高可能表明在1型糖尿病相关并发症患者中这种脂肪细胞因子的调节发生了改变。